Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 5, 2011, Pages 825-828

  Mahachai, Varocha ^a   Sirimontaporn, Nathavut ^a   Tumwasorn, Somying ^a   Thong Ngam, Duangporn ^b   Vilaichone, Ratha Korn ^c  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

Author keywords

Dyspepsia

Indexed keywords

ADENINE; AMOXICILLIN; CLARITHROMYCIN; GUANINE; LANSOPRAZOLE; NITROIMIDAZOLE; RNA 23S; UREASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BITTER TASTE; CONTROLLED STUDY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROSCOPY; GENE SEQUENCE; GENOTYPE; HEART PALPITATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA GENE; SIDE EFFECT; STOMACH ANTRUM; STOMACH BIOPSY; THAILAND; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST;

EID: 79954515517     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06660.x     Document Type: Article

References (25)

1. Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori: diagnosis and management. Gastroenterol. Clin. North Am. 2006; 35: 229-47.
2. Malfertheiner P, Megraud F, O'Morain C etal. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81.
3. Fuccio L, Minardi ME, Zagari RM etal. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann. Intern. Med. 2007; 147: 553-62.
4. Vakil N, Lanza F, Schwartz H etal. Seven-day therapy for Helicobacter pylori in the United States. Aliment. Pharmacol. Ther. 2004; 20: 99-107.
5. Scaccianoce G, Hassan C, Panarese A etal. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. Can. J. Gastroenterol. 2006; 20: 113-7.
6. Mahachai V, Thong-Ngam D, Noophun P etal. Efficacy of clarithromycin-based triple therapy for treating Helicobacter pylori in Thai non-lcer dyspeptic patients with clarithromcin resistant strains. J. Med. Assoc. Thai. 2006; 89 (Suppl. 3): S74-8.
7. De Francesco V, Margiotta M, Zullo A etal. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann. Intern. Med. 2006; 144: 94-100.
8. Vilaichone RK, Gamnarai P, Mahachai V. Antibiotic Resistance of Helicobacter pylori in Thailand (M1131 (593)). 2010, Digestive Disease Week (DDW), New Orlenes, LA, USA.
9. Zullo A, De Francesco V, Hassan C etal. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007; 56: 1353-7.
10. Sirimontaporn N, Thong D, Tumwasorn S etal. Ten-day sequential therapy of Helicobacter pylori infection in Thailand. Am. J. Gastroenterol. 2010; 105: 1071-5.
11. Versalovic J, Shortridge D, Kibler K etal. Mutations in 23S r RNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 1996; 40: 477-80.
12. Taylor DE, Ge Z, Purych D etal. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother. 1997; 41: 2621-8.
13. Raymond J, Lamarque D, Kalach N etal. High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter 2010; 15: 21-7.
14. Ahmad N, Zakaria WR, Abdullah SA etal. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. World J. Gastroenterol. 2009; 15: 3161-5.
15. Matsumura M, Hikiba Y, Ogura K etal. Rapid detection of mutations in the 23SrRNA gene of Helicobacter pylori that confers resistance to clarithromyc in treatment to the bacterium. J. Clin. Microbiol. 2001; 39: 691-5.
16. Oleastro M, Me'nard A, Santos A etal. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J. Clin. Microbiol. 2003; 41: 397-402.
17. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-84.
18. Versalovic J, Osato MS, Spakovsky K etal. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J. Antimicrob. Chemother. 1997; 40: 283-6.
19. Van Doorn LJ, Glupczynski Y, Kusters JG etal. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob. Agents Chemother. 2001; 45: 1500-4.
20. De Francesco V, Zullo A, Hassan C etal. Two new treatment regimens for Helicobacter pylori eradication: a randomized study. Dig. Liver Dis. 2001; 33: 676-9.
21. Kwon JH, Lee DH, Song BJ etal. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study. Helicobacter 2010; 15: 148-53.
22. Gao XZ, Qiao XL, Song WC etal. Standard triple, bismuth pectin quadruple and wequential therapies for Helicobacter pylori eradication. World J. Gastroenterol. 2010; 16: 4357-62.
23. Wu DC, Hsu PI, Wu JY etal. Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection. Clin. Gastroenterol. Hepatol. 2010; 8: 36-41.
24. Thailand consensus for the management of functional dyspepsia and Helicobacter pylori infection. Blueprint to practitioners. 2010.
25. Wonkusolatham P, Vilaichone RK, Kullavanijaya P etal. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strainwith metronidazole containing regimen in Thai patients with peptic ulcer disease. J. Med. Assoc. Thai. 2001; 84 (Suppl. 1): S474-80.